FDA.reportPublic FDA data

secukinumab 300 MG per 2 ML Auto-Injector

RxCUI
2637347
RxNorm name
secukinumab 300 MG per 2 ML Auto-Injector
Display name
secukinumab 300 MG per 2 ML Auto-Injector
Full name
secukinumab 300 MG per 2 ML Auto-Injector
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:04

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125504Cosentyxsecukinumab351(a)Rx2026-09-01
761349Cosentyxsecukinumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
77c4b13e-7df3-42d4-81db-3d0cddb7f67asecukinumab 300 MG in 2 ML Auto-Injector [PSN] · 2 ML secukinumab 150 MG/ML Auto-Injector [SCD] · secukinumab 300 MG per 2 ML Auto-Injector [SY]329These highlights do not include all the information needed to use COSENTYX safely and effectively. See full prescribing information for COSENTYX. COSENTYX ® (secukinumab) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201520260417